Liquid BiOpsy, Lung and Colon Cancer in AndaluciA

Launched by FUNDACIÓN PÚBLICA ANDALUZA PARA LA INVESTIGACIÓN BIOMÉDICA ANDALUCÍA ORIENTAL · May 21, 2025

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• General criteria:
• • More than 18 years old
• • Both genders
• • Ability to provide written informed consent
• Specific criteria:
• • NSCLC
• • Patients diagnosed with the 8th Edition of the Tumor, Node, Metastasis (TNM) staging system for Lung Cancer approved by International Association for the Study of Lung Cancer (IASLC) and the American Joint Committee on Cancer (AJCC): IV (Any T, Any N, M1a-c)
• • Histologically confirmed NSCLC (adenocarcinoma)
• • Performance status of 0-2 (ECOG PS) ○ Estimated life expectancy ≥3 months
• • Treatment naïve patients (chemotherapy, immunotherapy, targeted therapy, radiotherapy).
• • Smokers or Non-Smokers
• • CRC
• • Patients diagnosed with the Tumor, Node, Metastasis (TNM) staging system for Colorectal Cancer approved by the American Joint Committee on Cancer (AJCC): IV (Any T, Any N, M1a-c)
• • Histologically confirmed CRC (adenocarcinoma)
• • Performance status of 0-2 (ECOG PS)
• • Estimated life expectancy ≥3 months
• • Treatment naïve patients (chemotherapy, immunotherapy, targeted therapy, radiotherapy).
• Exclusion Criteria:
• • General: History of any other cancer within the previous 5 years, except non-melanoma skin cancer
• • General: Absence of Informed consent. \> Pregnant or nursing women. \> Small cell lung cancer.